Prior Art Litigation Search in Madrid.

A prior art search Madrid litigators can rely on has to be built for the way Spain actually enforces patents — nationally, before specialised commercial courts, and entirely outside the Unified Patent Court. Madrid is the seat of the Spanish Patent and Trademark Office (OEPM) and the corporate heart of the country: the base for Telefónica, Repsol, Iberdrola, BBVA and a dense cluster of pharmaceutical, telecoms and energy companies. When those portfolios are asserted, the validity fight is decided by a Spanish judge under national law, not by an international court in Munich or Paris. PerspireIP builds invalidity-grade searches for the parties challenging those patents before the Spanish commercial courts, the OEPM and the EPO.

Where a prior art search Madrid case is actually heard

Spanish patent litigation is not spread across every court in the country. Under a designation by the General Council of the Judiciary (Consejo General del Poder Judicial), patent claims are concentrated in specialised commercial courts (juzgados de lo mercantil) in a handful of cities. In Madrid, Commercial Courts numbers 7, 8, 9 and 10 hear patent matters; in Barcelona it is Commercial Courts 1, 4 and 5; and Valencia is the third traditional venue. Since 2019 the roster has widened to include Granada, Las Palmas, A Coruña and Bilbao, but the centre of gravity remains Barcelona and Madrid.

Barcelona is the preferred forum for many patentees, prized for its experienced patent judges and its more agile, predictable case management. Madrid, however, is where a great many defendants sit — it is the registered seat of the companies most often accused — and Madrid’s specialised commercial courts hear a substantial share of the national docket. Which venue a case lands in shapes timing and tactics, but it does not change the search: a Spanish judge decides novelty and inventive step on the prior art in front of them.

• Commercial Courts 7-10, Madrid — the specialised juzgados de lo mercantil that hear Madrid patent infringement and validity
• Commercial Courts 1, 4 and 5, Barcelona — the country’s busiest and most experienced patent venue
• No bifurcation — the same court decides infringement and validity together, unlike Germany
• OEPM and EPO — post-grant opposition routes that run in parallel to the courts

Spain sits outside the Unified Patent Court

This is the single fact that most distinguishes a Spanish patent dispute from one in Germany, France or the Netherlands. Spain never joined the unitary patent package — it did not sign the Agreement on a Unified Patent Court and does not participate in the Unitary Patent. The UPC has no jurisdiction over patents in Spain, and no unitary patent takes effect here. A European patent is only enforceable in Spain once it has been validated at the OEPM, which requires a full translation of the specification into Spanish.

The consequence for invalidity strategy is direct. A European patent validated in Spain is litigated nationally, before the specialised commercial courts in Madrid, Barcelona or Valencia, under the Spanish Patent Act — not before a UPC central or local division. There is no opt-out to worry about and no unitary revocation to file, because neither the unitary patent nor the UPC reaches Spain. Prior art scoped for a Spanish nullity action, and for EPO opposition where the patent has a European parent, is what actually decides the case here.

That national character also means a patentee running a pan-European campaign has to fight Spain separately. A win or loss at the UPC does not bind a Madrid court, so the Spanish front is a distinct battle — one where locally scoped, Spanish-language-ready prior art gives the accused party its own path to invalidity, independent of whatever is happening in the unitary system.

Nullity under Spain’s 2015 Patent Act

Spanish patent validity is governed by Law 24/2015 on Patents (Ley 24/2015, de 24 de julio, de Patentes), which came fully into force on 1 April 2017 and replaced the 1986 statute. The Act made a decisive change: every Spanish national patent is now granted only after a substantive examination of novelty and inventive step, ending the old optional, largely unexamined route. Patents granted under the current law therefore carry an examiner’s search behind them — but many patents still in force, and every pre-2017 right, do not.

Nullity is dealt with in Title X of the Act. A patent can be declared null where its subject-matter is not patentable — principally for lack of novelty or lack of inventive step — where the specification does not disclose the invention clearly and completely enough to be carried out, where the granted claims extend beyond the application as filed (added matter), or where the proprietor was not entitled to the patent. Novelty and inventive step are the grounds that turn on prior art, and they are where an invalidity search does its work.

Critically, Spain does not bifurcate. An accused party sued for infringement raises invalidity by way of counterclaim or defence in the same proceeding, and the commercial court rules on validity and infringement together in a single judgment. When nullity is pleaded by counterclaim, the patentee is given time to respond and may seek to limit the claims. That single-forum structure means the invalidity search cannot be an afterthought: the art you bring is the art the judge weighs against the asserted claims at trial.

• Lack of novelty — a single earlier disclosure that anticipates the claim
• Lack of inventive step — obviousness over the prior art, often a combination of references
• Insufficiency — the specification does not enable the skilled person to work the invention
• Added matter — the granted claims reach beyond the application as filed
• Entitlement — the proprietor is not the person entitled to the patent

Pharma, telecoms and energy: where Madrid’s patent fights come from

Madrid’s litigation profile follows the industries headquartered there. The city is Spain’s corporate capital and the home of the IBEX 35: Telefónica in telecoms, Repsol in oil and energy, Iberdrola in electricity and renewables, and BBVA in banking all base their operations here, alongside a deep bench of pharmaceutical and generic-drug companies and technology multinationals with their Spanish and southern-European headquarters in the region. It is also the seat of the OEPM itself. When a patent is asserted against a company registered in Madrid, the defendant is usually sued at its own domicile — which is exactly why so many disputes are anchored to the capital.

Those industries pull the prior art in different directions. Life-sciences assertions — small molecules, formulations, dosage regimes, biologics and devices — are among the most hard-fought in Spain, driven by generic and biosimilar entrants timing a launch against an originator’s patent. Preliminary injunctions and their inventive-step defences are a recurring flashpoint. Telecoms and energy assertions, by contrast, reach into standards documentation, network and grid technology, metering, and connectivity, where the decisive reference is often a standard contribution, a datasheet or a conference paper the examiner never saw.

For each of these accused parties — a generic manufacturer clearing a launch, a telecoms operator facing a standards-related assertion, an energy or renewables company sued over a grid or metering patent — the commercial stakes ride on whether the asserted claim can be shown to be old. In a single-forum system with no bifurcation, the most durable answer is nearly always a piece of dated, on-point prior art the patentee’s own examiner never reviewed.

Two opposition routes: the OEPM and the nine-month EPO window

Alongside the courts, Spain offers administrative attacks on a patent, and the right one depends on where the patent came from. For a Spanish national patent granted under Law 24/2015, third parties can file an opposition at the OEPM within six months of grant — a post-grant procedure modelled on the European system. It puts novelty and inventive step before the office that granted the patent, without the cost and exposure of a full court action.

For the many valuable patents asserted in Madrid that arrive as European patents validated in Spain, the more powerful route is EPO opposition, filed within nine months of grant. A successful EPO opposition revokes the patent centrally in every state where it was validated, Spain included, in a single proceeding on the same novelty, inventive-step, added-matter and sufficiency grounds a Spanish court would apply. Because Spain cannot use the UPC, the EPO is the one genuinely central forum available for a Spanish dispute.

Both windows close hard. Once the OEPM’s six months or the EPO’s nine months have passed, the accused party is left with national nullity before the Madrid or Barcelona commercial courts. Where a window is still open, opposition and national nullity are partners rather than rivals: one rigorous prior art search, charted claim by claim, can feed an opposition and a court action at once, so the same references do double duty. That is why we treat the grant date of any asserted patent as a hard diary entry the moment we are instructed.

How PerspireIP builds a Madrid invalidity search

Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date on the cover. For life-sciences assertions we run patent searching alongside deep non-patent retrieval — journal literature, clinical-trial registries, regulatory filings and conference abstracts. For telecoms and energy claims we reach the standards record, technical contributions, product documentation, datasheets and archived web pages, dating every reference to the day.

• Claim charting mapped to novelty and inventive step under Law 24/2015 and the EPC
• Deep non-patent retrieval across scientific, clinical, standards and grey-literature sources
• Public-availability dating for every reference, evidenced for journals and online disclosures alike
• Prior art scoped to your forum — a commercial-court nullity counterclaim, an OEPM opposition, or the nine-month EPO window
• Search results and disclosures readied for use in Spanish proceedings, translation-friendly for validated European patents

We work alongside your Spanish and European counsel as a specialist search partner, deliver to court and opposition deadlines, and keep every engagement confidential. Whether you are a generic pharmaceutical company clearing a launch, a telecoms or energy business facing an assertion, or litigation counsel preparing a nullity defence for a multinational’s Madrid operation, we scale to fit — a single search, a multi-patent campaign, or ongoing portfolio support. Because Spain is litigated nationally and outside the UPC, a prior art search Madrid teams commission has to stand on Spanish law and its own evidence. Send us the patent number and your key dates, and we will scope the work within one business day.

IP Landscape & Resources in Madrid

Key intellectual-property authorities and venues relevant to Madrid:

• Spanish Patent and Trademark Office (OEPM) — the national IP office in Madrid that grants Spanish patents, validates European patents in Spain, and hears post-grant opposition within six months of grant
• Law 24/2015 on Patents (BOE) — the consolidated Spanish Patent Act on the Boletín Oficial del Estado, setting the nullity grounds in Title X, including lack of novelty and inventive step
• General Council of the Judiciary (Poder Judicial) — the body that designated the specialised commercial courts (juzgados de lo mercantil) in Madrid, Barcelona and Valencia that hear Spanish patent cases
• European Patent Office (EPO) — grants European patents validated in Spain and runs post-grant opposition, a central attack filed within nine months of grant

Request a Prior Art Search in Madrid

Explore related PerspireIP services: Prior Art Litigation Search · Patent Invalidation · Patent Infringement Analysis.

Frequently Asked Questions